Phathom Pharmaceuticals (PHAT)'s 30-day implied volatility (IV30) was 109.4% at the close on October 23, 2026, up from 62.6% the day before, against a 52-week range of 37.2% to 125.5%. Its 20-day historical volatility was 58.6%.
Data as of October 23, 2026.